April 28, 2021

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.

Israeli Medical Cannabis Inhaler Gets Canada’s Marketing Nod

Approval is the first by an international regulator allowing the marketing of a precisely dosed cannabis inhaler as a medical product, Syqe® Medical says.

Great Love Can Conquer The Strongest Pain – Nelly & Guy

07/02/2022

A heartwarming testimonial movie about true love, starring our patient, Nelly, and her spouse, Guy. A story of love and partnership in the shadow of chronic pain.

Bedrocan Spotlights Syqe’s Clinical Research on Gender Differences in Medical Cannabis Inhalation

01/09/2024

An article by Bedrocan about Syqe®’s study showed that women and men who suffer from chronic neuropathic pain respond to medical cannabis in a similar when administered through the SyqeAir Inhaler.

Does Adding CBD to THC-Rich Cannabis Reduce the Side Effects of THC? / Dr. Joshua Aviram

20/03/2023

There are many myths and common beliefs about the THC and CBD ingredients of cannabis among the general public. Are these perceptions backed by clinical studies?

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: April 28, 2021

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

Israeli Medical Cannabis Inhaler Gets Canada’s Marketing Nod

Related Posts

Great Love Can Conquer The Strongest Pain – Nelly & Guy

Bedrocan Spotlights Syqe’s Clinical Research on Gender Differences in Medical Cannabis Inhalation

Does Adding CBD to THC-Rich Cannabis Reduce the Side Effects of THC? / Dr. Joshua Aviram